Free Trial
NASDAQ:NUTX

Nutex Health (NUTX) Stock Price, News & Analysis

Nutex Health logo
$127.72 +4.83 (+3.93%)
As of 10:14 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Nutex Health Stock (NASDAQ:NUTX)

Key Stats

Today's Range
$123.98
$127.70
50-Day Range
$104.81
$177.21
52-Week Range
$4.16
$184.28
Volume
19,504 shs
Average Volume
83,023 shs
Market Capitalization
$710.15 million
P/E Ratio
10.65
Dividend Yield
N/A
Price Target
$262.50
Consensus Rating
Buy

Company Overview

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

Nutex Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
66th Percentile Overall Score

NUTX MarketRank™: 

Nutex Health scored higher than 66% of companies evaluated by MarketBeat, and ranked 357th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nutex Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nutex Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Nutex Health's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nutex Health is 10.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.09.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nutex Health is 10.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.25.

  • Price to Book Value per Share Ratio

    Nutex Health has a P/B Ratio of 3.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Nutex Health's valuation and earnings.
  • Percentage of Shares Shorted

    10.26% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 69.80%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nutex Health does not currently pay a dividend.

  • Dividend Growth

    Nutex Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    10.26% of the float of Nutex Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Nutex Health has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nutex Health has recently increased by 69.80%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nutex Health has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Nutex Health this week, compared to 2 articles on an average week.
  • Search Interest

    14 people have searched for NUTX on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Nutex Health to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nutex Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $81,810.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    36.92% of the stock of Nutex Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 5.32% of the stock of Nutex Health is held by institutions.

  • Read more about Nutex Health's insider trading history.
Receive NUTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutex Health and its competitors with MarketBeat's FREE daily newsletter.

NUTX Stock News Headlines

The #1 AI Energy Stock
Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.
Nutex Health appoints Grant Thornton as new auditor
See More Headlines

NUTX Stock Analysis - Frequently Asked Questions

Nutex Health's stock was trading at $31.69 at the beginning of 2025. Since then, NUTX shares have increased by 287.8% and is now trading at $122.90.
View the best growth stocks for 2025 here
.

Nutex Health Inc. (NASDAQ:NUTX) released its earnings results on Tuesday, May, 13th. The company reported $2.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.15) by $2.71. The company earned $211.79 million during the quarter, compared to the consensus estimate of $81.09 million. Nutex Health had a net margin of 10.76% and a trailing twelve-month return on equity of 42.08%.
Read the conference call transcript
.

Shares of Nutex Health reverse split on the morning of Wednesday, July 3rd 2024.The 1-10 reverse split was announced on Wednesday, July 3rd 2024. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Shares of NUTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutex Health investors own include Predictive Oncology (POAI), Ford Motor (F), Wells Fargo & Company (WFC), JPMorgan Chase & Co. (JPM), Abbott Laboratories (ABT), Bank of America (BAC) and Cricut (CRCT).

Company Calendar

Last Earnings
5/13/2025
Today
6/30/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Business Services
Current Symbol
NASDAQ:NUTX
Employees
1,150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$262.50
High Stock Price Target
$300.00
Low Stock Price Target
$225.00
Potential Upside/Downside
+113.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
10.34
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$52.18 million
Pretax Margin
27.66%

Debt

Sales & Book Value

Annual Sales
$479.95 million
Cash Flow
$13.17 per share
Price / Cash Flow
9.33
Book Value
$37.13 per share
Price / Book
3.31

Miscellaneous

Free Float
3,504,000
Market Cap
$683.32 million
Optionable
Not Optionable
Beta
0.03
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:NUTX) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners